...
机译:法呢X受体通过MiR-135A1 / CCNG2信号通路抑制人结肠直肠癌细胞的增殖
Harbin Med Univ Affiliated Hosp 2 Dept Gen Surg Harbin 150001 Heilongjiang Peoples R China;
Harbin Med Univ Affiliated Hosp 2 Dept Gen Surg Harbin 150001 Heilongjiang Peoples R China;
Harbin Med Univ Affiliated Hosp 2 Dept Gen Surg Harbin 150001 Heilongjiang Peoples R China;
Harbin Med Univ Affiliated Hosp 2 Dept Gen Surg Harbin 150001 Heilongjiang Peoples R China;
Harbin Med Univ Affiliated Hosp 2 Dept Gen Surg Harbin 150001 Heilongjiang Peoples R China;
colorectal cancer; miR-135A1; cyclin G2; farnesoid X receptor; proliferation;
机译:法呢X受体通过MiR-135A1 / CCNG2信号通路抑制人结肠直肠癌细胞的增殖
机译:甲状腺激素受体1通过抑制人结肠直肠癌细胞中的PI3K / Akt信号传导来抑制增殖和迁移
机译:阿魏酸衍生物FXS-3通过阳性JNK信号通路和阴性ERK / p38,AKT / mTOR和MEK / ERK信号通路抑制人肺癌A549细胞的增殖和转移
机译:朝向无血清培养基:鉴定人生长受体和调节人间充质干细胞中细胞增殖的信号通路(MSC)
机译:多靶点受体酪氨酸激酶抑制剂利尼法尼(ABT-869)通过磷酸肌醇3激酶(PI3K)/ AKT依赖性信号传导途径诱导凋亡并抑制白血病细胞的增殖。
机译:NK1受体拮抗剂NKP608通过Wnt信号通路抑制人大肠癌细胞的增殖
机译:法呢X受体通过miR-135a1 / ccng2信号通路抑制人结肠直肠癌细胞的增殖